Suppr超能文献

肥胖与 COVID-19 肺炎疾病严重程度增加相关:系统评价和荟萃分析。

Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.

机构信息

Department of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310006, Zhejiang, China.

Department of Cardiology, Jinyun People's Hospital, No. 299 North Ziwei Road, Jinyun, 321400, Zhejiang, China.

出版信息

Eur J Med Res. 2020 Dec 2;25(1):64. doi: 10.1186/s40001-020-00464-9.

Abstract

BACKGROUND

Obesity has been widely reported to be associated with the disease progression of coronavirus disease 2019 (COVID-19); however, some studies have reported different findings. We conducted a systematic review and meta-analysis to investigate the association between obesity and poor outcomes in patients with COVID-19 pneumonia.

METHODS

A systematic review and meta-analysis of studies from the PubMed, Embase, and Web of Science databases from 1 November 2019 to 24 May 2020 was performed. Study quality was assessed, and data extraction was conducted. The meta-analysis was carried out using fixed-effects and random-effects models to calculate odds ratios (ORs) of several poor outcomes in obese and non-obese COVID-19 patients.

RESULTS

Twenty-two studies (n = 12,591 patients) were included. Pooled analysis demonstrated that body mass index (BMI) was higher in severe/critical COVID-19 patients than in mild COVID-19 patients (MD 2.48 kg/m, 95% CI [2.00 to 2.96 kg/m]). Additionally, obesity in COVID-19 patients was associated with poor outcomes (OR = 1.683, 95% CI [1.408-2.011]), which comprised severe COVID-19, ICU care, invasive mechanical ventilation use, and disease progression (OR = 4.17, 95% CI [2.32-7.48]; OR = 1.57, 95% CI [1.18-2.09]; OR = 2.13, 95% CI [1.10-4.14]; OR = 1.41, 95% CI [1.26-1.58], respectively). Obesity as a risk factor was greater in younger patients (OR 3.30 vs. 1.72). However, obesity did not increase the risk of hospital mortality (OR = 0.89, 95% CI [0.32-2.51]).

CONCLUSIONS

As a result of a potentially critical role of obesity in determining the severity of COVID-19, it is important to collect anthropometric information for COVID-19 patients, especially the younger group. However, obesity may not be associated with hospital mortality, and efforts to understand the impact of obesity on the mortality of COVID-19 patients should be a research priority in the future.

摘要

背景

肥胖与 2019 年冠状病毒病(COVID-19)的疾病进展广泛相关;然而,一些研究报道了不同的结果。我们进行了一项系统评价和荟萃分析,以研究肥胖与 COVID-19 肺炎患者不良结局之间的关系。

方法

对 2019 年 11 月 1 日至 2020 年 5 月 24 日期间来自 PubMed、Embase 和 Web of Science 数据库的研究进行了系统评价和荟萃分析。评估了研究质量并进行了数据提取。使用固定效应和随机效应模型进行荟萃分析,以计算肥胖和非肥胖 COVID-19 患者几种不良结局的优势比(OR)。

结果

纳入了 22 项研究(n=12591 例患者)。汇总分析表明,严重/危重症 COVID-19 患者的 BMI 高于轻症 COVID-19 患者(MD 2.48kg/m,95%CI [2.00 至 2.96kg/m])。此外,COVID-19 患者肥胖与不良结局相关(OR=1.683,95%CI [1.408-2.011]),包括严重 COVID-19、重症监护、有创机械通气使用和疾病进展(OR=4.17,95%CI [2.32-7.48];OR=1.57,95%CI [1.18-2.09];OR=2.13,95%CI [1.10-4.14];OR=1.41,95%CI [1.26-1.58])。肥胖作为危险因素在年轻患者中更大(OR 3.30 比 1.72)。然而,肥胖并没有增加医院死亡率的风险(OR=0.89,95%CI [0.32-2.51])。

结论

由于肥胖在决定 COVID-19 严重程度方面可能具有关键作用,因此收集 COVID-19 患者的人体测量信息非常重要,特别是年轻患者。然而,肥胖可能与医院死亡率无关,未来应优先研究肥胖对 COVID-19 患者死亡率的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/7709325/991497ebce8c/40001_2020_464_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验